Skip to content

    Galaxy Medicare financials

    Quarterly results

    cr · Quarterly
    Line itemQ2 FY25Q4 FY25Q2 FY26Q4 FY26
    Revenue17221921
    EBITDA3231
    Margin15%10%15%6%
    Net profit2221
    EPS1.441.401.330.92

    crore. Year-on-year against the same quarter last year.

    Performance63.6% 1Y

    Income Statement

    Financial Trajectories

    11
    Quarterly

    Balance Sheet

    Balance Sheet

    ₹ Cr · Annual
    Line itemFY21FY23FY24FY25FY26FY26
    LiabilitiesEquity Capital3312121515
    Reserves131510122425
    Borrowings998534
    Other Liabilities553334
    Total Liabilities303233314549
    AssetsFixed Assets141514141415
    CWIP000000
    Investments333333
    Other Assets131515152831
    Total Assets303233314549

    Cash Flow

    Cash Flow

    ₹ Cr · Annual
    Line itemFY21FY23FY24FY25FY26
    ActivitiesCash from Operating64342
    Cash from Investing-4-2-10-14
    Cash from Financing-1-2-2-512
    SummaryCapital Expenditure
    Free Cash Flow13340
    FCF Margin

    Ratios

    Ratios

    Annual
    RatioFY21FY23FY24FY25FY26YoY3-yr
    Returns19%18%14%−4.1 ppWorsening
    Leverage0.56×0.51×0.38×0.19×0.10×−0.09×Improving
    Working capital93107756570+5 dImproving
    741011248582−3 dImproving
    10292322236+14 d
    66116166127115−12 dStable
    136576995+26 dWorsening
    Payout10%0%0%0%33%+33.3 pp

    Margins, returns, leverage and efficiency are computed from the filed statements (year-end balances). Working-capital days and payout are as published by Screener — receivables and inventory sit inside other assets in our statements. 3-yr compares the latest year with three years earlier; small moves read as stable.

    Shareholding

    Who owns Galaxy Medicare Ltd

    As of Mar 2026 · 867 shareholders

    Since Sep 2025, DIIs trimmed −1.85 pp while the public added +1.29 pp. The shareholder count grew 1% to 867.

    Ownership split

    Promoters
    72.98%
    +0.55 pp QoQ
    Public
    27.02%
    +1.29 pp QoQ

    Ownership drift

    Last 2 disclosures on record

    • Promoters
    • DIIs
    • Public

    Percentages are as disclosed in the company's shareholding pattern filings. Named holders appear only above SEBI's 1% disclosure threshold, so a holder dropping off the list may have trimmed to just under 1% — or been re-filed under a new name — rather than exited.

    Assumptions

    Current — GML
    Price
    ₹17
    EPS (TTM)
    ₹5.09
    PE (TTM)
    3.3
    Profit growth

    The Earnings Per Share over the last 12 months.

    %

    Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).

    Pre-filled with the lower of median (3.2×) and current (3.3×) PE — the conservative anchor.

    %

    The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.

    Valuation

    Current price
    ₹17
    vs
    Fair value · 15% return
    ₹11
    37%Overvalued

    At 10% growth and a 3× exit, ₹17 only delivers your return if you pay ₹11. The price is currently baking in 20% growth.

    EPS grows 10%/yr for 5 years, then fades to 6% over 2, exits at 3×.

    YearGrowthEPS (₹)
    FY2710.0%5.60
    FY2810.0%6.16
    FY2910.0%6.77
    FY3010.0%7.45
    FY3110.0%8.20
    FY328.0% ·fade8.85
    FY336.0% ·fade9.38

    Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.

    Want to compare? Run the DCF calculator on any stock.

    Learn to analyse Galaxy Medicare Ltd

    Guides on how to read this kind of business and the numbers that matter.